Single Technologies News Today

Aplex Bio believes its technology has the sensitivity, specificity, and scale to challenge both digital PCR and next-generation sequencing-based applications.

December 21, 2020 December 21, 2020 | Funding updates around the life sciences including cash for a handheld mass spec device, Series D for oncolytic immunotherapy, a new company launch in allogenic CAR-NK cells, AI-powered cell classification, a 3-D sequencing platform, and more. $170M: Israeli ‘Digital Health First’ VC Firm OTV (formerly Olive Tree Ventures), Israel’s ‘digital health first’ venture capital firm, today announced the closing of a fund with a total value o...